How overweight do you need to be for Mounjaro?

Does your BMI have to reach a specific number, or does it depend on something else too?

The number people usually hear first is 30. That is the BMI at which Mounjaro's UK licence applies without any additional conditions being required. If your BMI sits between 27 and 29.9, the licence still covers you, but only when you also have at least one weight-related health condition. Conditions that count include type 2 diabetes, high blood pressure, dyslipidaemia (raised cholesterol or triglycerides), and obstructive sleep apnoea, among others.

So the honest answer to "how overweight do you need to be for Mounjaro" is: it depends on the full picture. A BMI of 28 with a diagnosis of hypertension puts you within the licensed criteria. A BMI of 28 with no other relevant conditions does not. Our page on BMI requirements for Mounjaro goes into the numbers in more detail, including how BMI is calculated and where the thresholds come from.

It is also worth knowing that BMI has recognised limitations as a measure of health. It does not capture where fat is distributed in the body, or how weight is affecting you day to day. A prescriber looks at the broader context, not just the number on a calculator. The NHS BMI calculator can give you your figure, which is a useful first step before a consultation.

What if your BMI is below 30, can you still be considered?

A question our prescribers hear most weeks is whether Mounjaro is available to people who feel they need to lose weight but whose BMI falls below 30. The clinical answer is careful. If you are wondering how overweight you need to be for Mounjaro, the licensed threshold of 27 with a qualifying condition is already an accommodation for people with a lower BMI who carry meaningful health risk because of their weight. Below 27, the medicine is not licensed for weight management in the UK, and a responsible prescriber will not prescribe outside those parameters.

There is a separate consideration for ethnic background. UK clinical guidance, informed by NICE's appraisal of tirzepatide (TA1026), recognises that BMI thresholds should be 2.5 kg/m² lower for people of South Asian, Chinese, Middle Eastern, Black African, or African-Caribbean backgrounds, because health risks from excess weight occur at lower BMI values in these groups. So for someone in one of those groups, the relevant figures shift to 27.5 or above without conditions, or 24.5 or above with a qualifying condition.

If you are unsure whether you qualify, our page covering whether Mounjaro is an option if you are not overweight addresses this specific situation in more depth.

How does NHS eligibility differ from private prescribing?

NHS access to Mounjaro follows a separate, stricter set of criteria set out by NICE in technology appraisal TA1026. The rollout is phased: from June 2025, the NHS prioritises adults with a BMI of 40 or above alongside four or more qualifying conditions; a second cohort covering BMI 35 to 39.9 with four or more conditions was activated in June 2026. Further phases will extend access over coming years, each with different BMI and condition thresholds.

Private prescribing works from the licensed thresholds described above (BMI 30 or above, or 27 or above with a qualifying condition) which are broader than the current NHS criteria. That distinction matters for people who meet the licence criteria but not the NHS phase criteria, or who would prefer not to wait for a referral. Our guide to getting Mounjaro for weight loss explains both routes clearly.

Whichever route you consider, the same clinical logic applies: the BMI threshold opens the door, but a prescriber still has to confirm the medicine is appropriate for you. Eligibility is a clinical judgement, not an automated tick-box.

What else does a prescriber check beyond your BMI?

Once your BMI meets the threshold, a prescriber is looking at a wider set of factors. Mounjaro is not appropriate during pregnancy, breastfeeding, or if you are trying to conceive. It is not licensed for people under 18. Certain conditions (including a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, or a history of pancreatitis) require careful discussion and may mean another treatment is more suitable.

Other medicines you take are also assessed, partly because Mounjaro slows gastric emptying, which can affect how quickly oral medicines are absorbed. Women taking oral contraceptives need to use an additional barrier method during the first four weeks of treatment and for four weeks after any dose increase, as the pill's absorption may be reduced.

None of this is meant to be discouraging. It is why a proper consultation matters. Questions about how overweight you have to be to get Mounjaro, or about practical matters such as whether you can get Mounjaro on Klarna, are all covered in our supporting pages. A prescriber at our clinical team reviews your answers personally before any prescription is issued. If you are ready to see whether you are eligible, you can start with a free consultation and the assessment goes from there.